New MRI aims to spare kidney patients unnecessary surgery

NCT ID NCT07173140

First seen Nov 01, 2025

Summary

This study tests whether advanced MRI scans can tell the difference between aggressive and harmless kidney tumors. Currently, scans can find tumors but not their type, often leading to invasive biopsies or unnecessary surgery. Researchers will give 30 patients an extra MRI before surgery and compare the images to the actual tumor tissue. If the new MRI works, it could help doctors decide which tumors truly need treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University College London

    London, United Kingdom

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MRI scan with novel sequences

What this could lead to

If successful, this could lead to a non-invasive way to identify which kidney tumors need surgery and which can be left alone.

What could go wrong

This is a small pilot study with only 30 people. The new MRI technique may not be accurate enough to replace biopsies or may not work for all tumor types.

Conditions

The condition(s) this trial relates to.

kidney cancer kidney neoplasm renal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.